Searchable abstracts of presentations at key conferences in endocrinology

ea0016p740 | Thyroid | ECE2008

Serum ghrelin levels are increased in hypothyroid patient and become normalized after L-thyroxin treatment

Gjedde Signe , Vestergaard Esben Thyssen , Gormsen Lars Christian , Riis Anne Lene , Rungby Jorgen , Moller Niels , Weeke Jorgen , Jorgensen Jens Otto

Context: An interaction between gut-derived ghrelin, which is implicated in the regulation of short- and long-term energy balance, and thyroid function has previously been reported in patients with hyperthyroidism, in whom ghrelin levels are reversibly suppressed. In the present study, we measured total serum ghrelin levels and pertinent metabolic indices in hypothyroid patients before end after L-thyroxin replacement.Patients and methods:...

ea0056ep161 | Thyroid | ECE2018

A TSH pituitary adenoma due to Hashimoto Thyroiditis and L-tiriiodotironin treatment experience: Case report

Eklioglu Beray Selver , Selver Muhammed Burak , Atabek Mehmet Emre

Aim: We report a child with reactive pituitary enlargement and microadenoma due to Hashimoto thyroiditis.We want to emphasize the importance of good endocrine evaluation in pediatric cases of pituitary adenomasCase report: A 7 year 7 month old boy presented with mild symptoms of hypothyroidism. There was no feature in his past medical story.He had normal cognitive and neurological development. At physical examination his weight was 24 kg (0.06 SDS) and h...

ea0014p324 | (1) | ECE2007

The effect of L-thyroxin theraphy on left ventricular diastolic dysfunction in patients with subclinical hypothyroidism

Saler Tayyibe , Saglam Zuhal Aydan , Korkmaz Kazim , Ataoglu Hayriye Esra , Yenigun Mustafa , Oguzhan Berrin

Aim: Subclinical Hypothyroidism (SH) is associated with cardiovascular disorders which may include increased risk for atherosclerosis, endothelial dysfunction and myocardial dysfunction.To investigate the prevalence of left ventricular systolic and diastolic dysfunction in patients with subclinical hypothyroidism and the effect of L-thyroxin therapy on myocardial performance using conventional echocardiographic parameters.Method: The study includes 95 pa...

ea0077p192 | Metabolism, Obesity and Diabetes | SFEBES2021

N-acetylmuramoyl-L-alanine amidase is a biomarker for remission of type 2 diabetes after bariatric surgery

Iqbal Zohaib , Fachim Helene , Gibson John , Baricevic-Jones Ivona , Campbell Amy , Geary Bethany , Donn Rachelle , Syed Akheel , Wetton Anthony , Soran Handrean , Heald Adrian

Aims: We used sequential window acquisition of all theoretical fragment ion spectra Mass Spectrometry (SWATH-MS) to identify proteins acting as markers of remission of type 2 diabetes (T2DM) in patients who lost weight after bariatric surgery.Background: Bariatric surgery results in remission of T2DM in up to 80% of patients. The mechanisms underpinning are largely unknown. N-acetylmuramoyl-L-alanine amidase (PGLRYP2) is an immune response enzyme that br...

ea0065p107 | Bone and calcium | SFEBES2019

Not all cases of hypercalcemia with calcium above 3.0 mmol/l and raised parathyroid hormone levels are due to primary hyperparathyroidism

Francis-Emmanuel Patrice , Tauni Rahat

Parathyroid hormone-dependent hypercalcaemia is one of the commonest conditions seen in endocrinology clinics. Primary hyperparathyroidism (PHPT) is the usual cause although some cases are due to other conditions including familial hypocalciuric hypercalcaemia (FHH). Making the distinction between PHPT and FHH is important in order to avoid unnecessary parathyroid surgery. Urinary calcium quantification is an integral part of diagnostic investigations. We present the case of a...

ea0049oc10.3 | Bone & Calcium Homeostasis | ECE2017

High prevalence of radiological vertebral fractures in patients with differentiated thyroid carcinoma undergoing L-thyroxine TSH-suppressive therapy

Formenti Anna Maria , Mazziotti Gherardo , Frara Stefano , Maffezzoni Filippo , Doga Mauro , Bertagna Francesco , Maroldi Roberto , Memo Maurizio , Giubbini Raffaele , Giustina Andrea

Thyroid hormones play a central role in the regulation of bone turnover and thyrotoxicosis is an established cause of secondary osteoporosis. Increased prevalence of reduced bone mineral density (BMD) has been reported even in patients with subclinical thyrotoxicosis such as those with differentiated thyroid carcinoma undergoing long-term L-thyroxine (L-T4) TSH-suppressive therapy. Morphometric vertebral fractures (VFs) are an early and clinically...

ea0032p798 | Paediatric endocrinology | ECE2013

Subclinical hypothyroidism in obese children: the influence of L-thyroxin treatment on metabolic comorbidities and a success of dietary therapy

Matusik Pawel , Januszek-Trzciakowska Aleksandra , Malecka-Tendera Ewa

Introduction: Subclinical hypothyroidism (sHT) is defined as elevated level of TSH with normal levels of thyroid hormone. In obese children there is a high frequency of this disturbance. However, the influence of sHT on therapy success and an appearance of metabolic complications in childhood obesity is unclear. Furthermore, the supplementation L-thyroxin (L-T4) in this case seems to be very controversial.Aim: The...

ea0020p85 | Thyroid | ECE2009

Is there any beneficial effect of L-thyroxine replacement theraphy on cardiovascular risk factors in patients with subclinical hypothyroidism?

Unal Oguz Kaan , Erturk Erdinc , Sarandol Emre , Eroz Esma , Kiyici Sinem , Guclu Metin , Imamoglu Sazi

The relationship between increased risk of cardiovascular disease (CVD) and atherosclerosis in subclinical hypothyroidism (sHT) have been demonstrated in several studies. This relation was attributed to dyslipidemia which is common in sHT. Apo A1, apo B100, Lp (a), hsC-reactive protein (hsCRP), fibrinogen and total homocysteinemia (tHcy) are the main non-traditional cardiovascular risk factors. In addition, paraoxon 1 (PON 1) activity is an enzyme responsible for the anti-oxid...

ea0020p273 | Clinical case reports and clinical reports | ECE2009

Transient ischemic attack after oral L-thyroxine loading test: a case report

Gul Ozen Oz , Kiyici Sinem , Unal Oguz Kaan , Cander Soner , Nizamoglu Ali , Erturk Erdinc , Imamoglu Sazi

Many causes of levothyroxine malabsorption have been described in the literature such as celiac disease, giardiasis, severe liver cirrhosis and drug interactions. A 27-year-old woman admitted to our institution with overt hypothyroidism symptoms. She had total thyroidectomy for thyroid papiller carcinoma and was using 400 μg/day levothyroxine (LT4). Her serum free thyroxine (fT4), free triiodothyronine (fT3) and thyrotropin stimulating hor...

ea0013p333 | Thyroid | SFEBES2007

Neuropsychological abnormalities in overt and sub-clinical hypothyroidism improve but do not normalise following 3 months replacement with L-thyroxine

Correia Neuman , Mullally Sinead , Tun Tommy Kyaw , Phelan Niamh , Fitzgibbon Maria , O’Mara Shane , Boran Gerard , Gibney James

The neuropsychological mechanism underlying cognitive impairment in hypothyroidism is poorly understood. It is not known whether cognitive impairment resolves following L-Thyroxine (LT4) replacement. It is also unknown whether similar neuropsychological abnormalities occur in patients with sub-clinical hypothyroidism (SCH). To address these questions, we performed neuropsychological tests in 17 patients with hypothyroidism (age 45±3 years; mean±S.E.M.)...